Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve ; day:31 ; month:10 ; year:2020 ; pages:1-9
PharmacoEconomics ; (31.10.2020), 1-9
- Klassifikation
-
Wirtschaft
- Urheber
-
Sendi, Pedram
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40273-020-00969-5
- URN
-
urn:nbn:de:101:1-2020121418594226447366
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sendi, Pedram
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Cost-effectiveness of Rotavirus vaccination in Vietnam
HIV prevention cost-effectiveness: a systematic review
The cost-effectiveness of exercise referral schemes
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Cost-effectiveness of Rotavirus vaccination in Vietnam
HIV prevention cost-effectiveness: a systematic review
The cost-effectiveness of exercise referral schemes
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Cost-effectiveness of Rotavirus vaccination in Vietnam
HIV prevention cost-effectiveness: a systematic review